Quantbot Technologies’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
CCM
NTCM
Quantbot Technologies's IRMD Position: Q2 2026 in Review
Quantbot Technologies reduced its iRadimed (IRMD) stake by 38% in Q2 2026, selling an estimated $306K and leaving 5,455 shares worth $521K. The position accounts for 0.02% of the portfolio, ranked #908.
Quantbot Technologies first reported a position in IRMD in Q1 2022 and has held it in 12 quarters since. The position peaked at $849K in Q1 2026. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.
- Quantbot Technologies held 5,455 shares of iRadimed worth $521K as of Q2 2026.
- Quantbot Technologies sold 3,363 iRadimed shares in Q2 2026, an estimated $306K.
- iRadimed made up 0.02% of Quantbot Technologies's portfolio in Q2 2026, its #908 holding.
- Quantbot Technologies first reported a position in iRadimed in Q1 2022 and has held it in 12 quarters since.
- Quantbot Technologies's iRadimed position peaked at $849K in Q1 2026.
- 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.
Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.